Roche Aktie

312,00 EUR +0,40 EUR +0,13 %

11:04:12

XETRA

289,20 CHF -2,00 CHF -0,69 %

11:42:54

SWX

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.248,15 Mrd. EUR

KGV26,06Div. Rendite3,58%

WKN851311

ISINCH0012032113

SymbolRHHBF

Roche Aktien News

Sortieren:Datum Meistgelesen

24.08.22PR NewswireRoche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq

23.08.22GlobeNewswireRoche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseases

22.08.22PR NewswireRoche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75

16.08.22GlobeNewswireFDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma

15.08.22GlobeNewswireRoche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2

12.08.22GlobeNewswireRoche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

11.08.22PR NewswireRoche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA

02.08.22GlobeNewswireRoche’s subcutaneous formulation of Tecentriq demonstrates positive Phase III results

28.07.22GlobeNewswireRoche to present scientific progress across Alzheimer’s disease pharmaceutical and diagnostic portfolio at 2022 AAIC Annual Meeting

22.07.22GlobeNewswireCHMP recommends EU approval of Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision loss

22.07.22PR NewswireRoche to showcase latest innovations in diagnostic solutions at American Association of Clinical Chemistry 2022 Clinical Lab Expo

21.07.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Board of Directors and Corporate Executive Committee in Spring 2023

21.07.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022

19.07.22GlobeNewswireRoche's Elecsys Amyloid Plasma Panel granted FDA Breakthrough Device Designation to enable a timely diagnosis of Alzheimer’s disease

18.07.22GlobeNewswireRoche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus

14.07.22GlobeNewswireEight-year data from APHINITY study show Roche’s Perjeta-based regimen continues to reduce the risk of disease returning for people with HER2-positive early breast cancer

14.07.22GlobeNewswireNew two-year data confirm Roche’s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration

11.07.22GlobeNewswireNew data from phase III HAVEN 6 study reinforce favourable safety and efficacy profile of Roche’s Hemlibra in people with moderate or mild haemophilia A

06.07.22GlobeNewswireFDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma

29.06.22GlobeNewswireRoche launches new BenchMark ULTRA PLUS system for cancer diagnostics enabling timely, targeted patient care

28.06.22GlobeNewswireRoche launches the VENTANA DP 600 slide scanner for digital pathology, enhancing patient care with precision diagnostics

16.06.22GlobeNewswireRoche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options

16.06.22GlobeNewswireRoche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease

15.06.22GlobeNewswireRoche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19

10.06.22GlobeNewswireRoche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting

09.06.22GlobeNewswireU.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)

09.06.22GlobeNewswireEuropean Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer

08.06.22GlobeNewswireEuropean Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma

31.05.22GlobeNewswireFDA approves Roche’s Evrysdi for use in babies under two months with spinal muscular atrophy (SMA)

27.05.22GlobeNewswireNew pivotal data demonstrate clinical benefit of Roche’s glofitamab, a potential first-in-class bispecific antibody for people with aggressive lymphoma

25.05.22GlobeNewswireRoche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma

25.05.22GlobeNewswireRoche develops unique PCR tests to detect the monkeypox virus

24.05.22GlobeNewswireData at the 2022 ASCO Annual Meeting highlight Roche’s continued commitment to innovation in oncology and personalised healthcare

12.05.22GlobeNewswireRoche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure

11.05.22GlobeNewswire[Ad hoc announcement pursuant to Art. 53 LR] Roche reports interim results for phase III SKYSCRAPER-01 study in PD-L1-high metastatic non-small cell lung cancer

10.05.22GlobeNewswireRoche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028

Roche News

Roche News: auf dieser Seite finden Sie alle Roche News und Nachrichten zur Roche Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Roche News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Roche News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.